|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02338427 |
|
Date of registration:
|
12/01/2015 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Capacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic Analysis
IPA |
|
Scientific title:
|
Capacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic Analysis. Multicenter Prospective |
|
Date of first enrolment:
|
May 2016 |
|
Target sample size:
|
140 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02338427 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Hervé MAISONNEUVE, PH |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Centre Hospitalier Départementel Vendée |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Upper age to 18 years
- Amylose diagnosis establish by tissue sample, after "Rouge Congo" coloration
- All patient with amylose identified by the two laboratory of anatomopathology
- Sample necessary for realized proteomic analysis
- No opposition at the participation of the study
- Patient sign an informed consent for biology collection
Exclusion Criteria:
- Tissue sample inadequate for apply immunohistochemistry or proteomic identification
- Patient trust, guardianship, under legal protection measure, deprived of freedom
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Amyloidosis
|
|
Intervention(s)
|
|
Other: Proteomic analysis
|
|
Other: Immunohistochemistry
|
|
Primary Outcome(s)
|
|
Identification success of amylose by immunohistochemistry and proteomic analysis
[Time Frame: Inclusion]
|
|
Secondary ID(s)
|
|
CHD 063-14
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|